Since completing the human genome in 2003, translating genomic discoveries into the clinic has rested largely on the ability to share linked genomic and associated clinical data. The heightened sensitivity of linked data, however, places special technical and ethical-legal demands on institutional infrastructures to keep such data secure, yet simultaneously useful for both clinical and secondary research use. In this talk, Ms. Rahimzadeh will discuss the regulatory and scientific levers for 'responsible' data sharing practices in genomics, and how these levers provide a platform upon which governance in this field can build.